We are a global, technology-enabled solutions partner for life sciences, uniting medical, commercial, and strategic expertise with purpose-built, AI-powered technology to accelerate patient access to life-changing treatments.
For more than 20 years, Envision Pharma Group has partnered with over 400 pharmaceutical, biotechnology, and medical technology companies to turn complexity into clarity and ideas into measurable, real-world impact.
Our vision is clear: to unleash the power of combined intelligence — human expertise and technology — to advance how scientific innovation translates into patient impact.
Every engagement is driven by this purpose: turning data into insight, insight into strategy, and strategy into measurable outcomes that matter for patients, healthcare providers, and society.
We are stronger together. Our diverse skills, perspectives, and experiences come to life through collaboration – creating better ideas, smarter solutions, and greater impact.
People are at the heart of everything we do. We support, respect, and inspire one another so everyone can thrive, grow, and do their best work.
We embrace change, curiosity, and new thinking. By challenging convention and encouraging innovation, we continue to evolve – as individuals, as teams, and as a business.
Our leaders bring together deep industry knowledge, scientific expertise, and a shared commitment to accelerating access to innovation. Their vision and experience guide Envision as we continue to grow, adapt, and innovate.
From our beginnings as a pioneer in publications planning to becoming a global partner in strategy, communications, technology, and commercialization, our story is one of growth, collaboration, and bold thinking.
Envision operates as one unified global organization, working seamlessly across the product lifecycle to deliver integrated, end-to-end solutions for life sciences clients.
Our model brings together advisory expertise and AI-powered technology platforms, enabling us to combine human insight and innovation at scale. This integrated approach drives smarter decisions, measurable impact, and sustainable growth – without silos, handovers, or fragmented delivery.
To ensure depth of expertise and focus, our capabilities are organized into five specialist business units, each supported by shared technology, data, and delivery infrastructure:
Providing evidence-led insight, strategy, and advisory support across the lifecycle.
Delivered through Two Labs, including Shepherds Safety Services, providing launch, market, and compliance services.
Delivered through Riparian, focused on pricing, access, and value optimization.
Delivered through four specialist agencies: Envision 90TEN, Envision Spark, Envision Ignite, and Envision Catalyst.
Underpinning every business unit and representing EnvisionOne and iEnvision, our AI-powered platforms connect data, insight, and execution.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
We bring together scientists, strategists, communicators, analysts, and technologists who share a challenger mindset. Experts, not generalists, our people work shoulder-to-shoulder with clients and one another, breaking silos to co-create smarter, faster solutions.
We are committed to advancing people, protecting the planet, and creating purposeful progress. Our approach to environmental, social, and governance (ESG) prioritizes sustainability, inclusion, and responsible growth – ensuring our solutions create value not only for clients and patients, but for society as a whole.
In 2025, we were awarded a Gold Medal in the EcoVadis Sustainability Assessment, placing us in the top 5% of companies assessed globally.
From early development through post-launch, we help life sciences companies create, communicate, and convert value. Let’s work together to accelerate access to innovation that changes lives.
